Edition:
United Kingdom

Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

3,635JPY
30 Sep 2016
Change (% chg)

¥-30 (-0.82%)
Prev Close
¥3,665
Open
¥3,640
Day's High
¥3,665
Day's Low
¥3,595
Volume
877,900
Avg. Vol
1,082,539
52-wk High
¥4,685
52-wk Low
¥3,110

4519.T

Chart for 4519.T

About

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transportation and storage of pharmaceutical products, as... (more)

Overall

Beta: 0.70
Market Cap(Mil.): ¥2,051,249.00
Shares Outstanding(Mil.): 559.69
Dividend: 26.00
Yield (%): 1.42

Financials

  4519.T Industry Sector
P/E (TTM): 32.06 36.94 36.87
EPS (TTM): 114.33 -- --
ROI: 9.80 14.36 13.86
ROE: 10.08 15.19 14.81

BRIEF-Chugai and Galderma announce global license agreement for Nemolizumab

* Chugai will continue to be responsible for product manufacturing and supply of Nemolizumab.

21 Jul 2016

BRIEF-Chugai Pharmaceutical says concluded a license agreement with Roche

* Announced that it concluded a license agreement with roche for "sa237"

01 Jun 2016

BRIEF-Chugai Pharmaceutical announces results of Japanese phase III study of Alecensa

* Announced results of Japanese phase III study of Alecensa in Alk fusion gene positive non-small cell lung cancer

19 May 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
£10.00
Provider : GlobalData
£195.00
Provider : MarketLine
£33.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.